INBX
Price
$13.33
Change
-$0.77 (-5.46%)
Updated
Apr 3 closing price
Capitalization
204.11M
54 days until earnings call
RAPT
Price
$1.11
Change
-$0.05 (-4.31%)
Updated
Apr 3 closing price
Capitalization
147.19M
34 days until earnings call
Ad is loading...

INBX vs RAPT

Header iconINBX vs RAPT Comparison
Open Charts INBX vs RAPTBanner chart's image
Inhibrx Biosciences
Price$13.33
Change-$0.77 (-5.46%)
Volume$220.45K
Capitalization204.11M
RAPT Therapeutics
Price$1.11
Change-$0.05 (-4.31%)
Volume$969.1K
Capitalization147.19M
INBX vs RAPT Comparison Chart
Loading...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INBX vs. RAPT commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INBX is a StrongBuy and RAPT is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (INBX: $13.33 vs. RAPT: $1.11)
Brand notoriety: INBX and RAPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INBX: 220% vs. RAPT: 131%
Market capitalization -- INBX: $204.11M vs. RAPT: $147.19M
INBX [@Biotechnology] is valued at $204.11M. RAPT’s [@Biotechnology] market capitalization is $147.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INBX’s FA Score shows that 2 FA rating(s) are green whileRAPT’s FA Score has 0 green FA rating(s).

  • INBX’s FA Score: 2 green, 3 red.
  • RAPT’s FA Score: 0 green, 5 red.
According to our system of comparison, INBX is a better buy in the long-term than RAPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INBX’s TA Score shows that 5 TA indicator(s) are bullish while RAPT’s TA Score has 4 bullish TA indicator(s).

  • INBX’s TA Score: 5 bullish, 3 bearish.
  • RAPT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, INBX is a better buy in the short-term than RAPT.

Price Growth

INBX (@Biotechnology) experienced а -6.91% price change this week, while RAPT (@Biotechnology) price change was -21.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

INBX is expected to report earnings on May 28, 2025.

RAPT is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INBX($204M) has a higher market cap than RAPT($147M). INBX YTD gains are higher at: -13.442 vs. RAPT (-29.747). INBX has higher annual earnings (EBITDA): 1.72B vs. RAPT (-134.9M). RAPT has more cash in the bank: 231M vs. INBX (196M). INBX has less debt than RAPT: INBX (1.84M) vs RAPT (4.49M). INBX has higher revenues than RAPT: INBX (1.57M) vs RAPT (0).
INBXRAPTINBX / RAPT
Capitalization204M147M139%
EBITDA1.72B-134.9M-1,277%
Gain YTD-13.442-29.74745%
P/E Ratio0.12N/A-
Revenue1.57M0-
Total Cash196M231M85%
Total Debt1.84M4.49M41%
TECHNICAL ANALYSIS
Technical Analysis
INBXRAPT
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 11 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EKJAX9.82N/A
N/A
Allspring Premier Large Co Gr A
PARWX51.74N/A
N/A
Parnassus Value Equity Investor
GSVSX15.75N/A
N/A
Goldman Sachs Large Cap Value Svc
ICWIX6.03N/A
N/A
Integrity Mid-North American Resources I
EEMPX8.16N/A
N/A
MFS Emerging Markets Equity Research A

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
-5.46%
AXON - INBX
48%
Loosely correlated
-3.35%
AKESF - INBX
45%
Loosely correlated
-7.01%
SNTI - INBX
39%
Loosely correlated
-6.54%
RAPT - INBX
38%
Loosely correlated
-4.31%
VCYT - INBX
37%
Loosely correlated
-5.51%
More

RAPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPT has been closely correlated with JBPHF. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if RAPT jumps, then JBPHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPT
1D Price
Change %
RAPT100%
-4.31%
JBPHF - RAPT
79%
Closely correlated
N/A
AXON - RAPT
48%
Loosely correlated
-3.35%
SNDX - RAPT
45%
Loosely correlated
-3.93%
SLGL - RAPT
45%
Loosely correlated
+3.31%
TRAW - RAPT
44%
Loosely correlated
-6.03%
More